<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:aacou="http://abonyacquisitioncorpI.com/20251231"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="aacou-20251231.xsd" xlink:type="simple"/>
    <context id="cref_145379145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-18</startDate>
            <endDate>2026-02-18</endDate>
        </period>
    </context>
    <context id="cref_256662356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:BTIGLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1037697349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aacou:UnderwritersAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_414420850">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-20</startDate>
            <endDate>2026-02-20</endDate>
        </period>
    </context>
    <context id="cref_908877115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aacou:UnderwritersAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_2007673822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-20</startDate>
            <endDate>2026-02-20</endDate>
        </period>
    </context>
    <context id="cref_138542282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_533141458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:BTIGLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_873881575">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_639467079">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_1295773837">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-20</startDate>
            <endDate>2026-02-20</endDate>
        </period>
    </context>
    <context id="cref_1262656910">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:BTIGLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-20</startDate>
            <endDate>2026-02-20</endDate>
        </period>
    </context>
    <context id="cref_587895388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-26</startDate>
            <endDate>2026-01-26</endDate>
        </period>
    </context>
    <context id="cref_32634712">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1021116441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
        </entity>
        <period>
            <startDate>2025-11-13</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_129871934">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1198982694">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_998287359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1701158294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1219919515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1712126357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:BTIGLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_823725382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_445481486">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-20</startDate>
            <endDate>2026-02-20</endDate>
        </period>
    </context>
    <context id="cref_215408277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-20</startDate>
            <endDate>2026-02-20</endDate>
        </period>
    </context>
    <context id="cref_507305422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-13</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_2079974558">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1845149687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_143874339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_2004087683">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-13</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_324529400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-13</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_120717459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">aacou:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_931987691">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-26</startDate>
            <endDate>2026-01-26</endDate>
        </period>
    </context>
    <context id="cref_2095354973">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-26</instant>
        </period>
    </context>
    <context id="cref_801357899">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">aacou:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-26</instant>
        </period>
    </context>
    <context id="cref_130466136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">aacou:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-26</startDate>
            <endDate>2026-01-26</endDate>
        </period>
    </context>
    <context id="cref_1206883864">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_2134472946">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">aacou:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-16</startDate>
            <endDate>2025-12-16</endDate>
        </period>
    </context>
    <context id="cref_734645114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-16</startDate>
            <endDate>2025-12-16</endDate>
        </period>
    </context>
    <context id="cref_95296787">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">aacou:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-16</startDate>
            <endDate>2025-12-16</endDate>
        </period>
    </context>
    <context id="cref_360245387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:InitialShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-28</startDate>
            <endDate>2025-11-28</endDate>
        </period>
    </context>
    <context id="cref_1077444195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">aacou:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-28</instant>
        </period>
    </context>
    <context id="cref_1729854016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">aacou:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-28</startDate>
            <endDate>2025-11-28</endDate>
        </period>
    </context>
    <context id="cref_972287698">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aacou:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_1197005563">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aacou:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:BTIGLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_2084948506">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aacou:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_542702771">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aacou:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-20</startDate>
            <endDate>2026-02-20</endDate>
        </period>
    </context>
    <context id="cref_1634986019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-13</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_551561350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-13</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1142121933">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_678862350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_2134791791">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_179795992">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-13</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_301617889">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_565461537">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-13</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_695008509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1538738852">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_1845833247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-20</startDate>
            <endDate>2026-02-20</endDate>
        </period>
    </context>
    <context id="cref_992778569">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1956966180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1094527778">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_840864601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_2040435108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-13</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1284822420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-13</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1601694498">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-13</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1237866555">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-27</instant>
        </period>
    </context>
    <context id="cref_887709007">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-27</instant>
        </period>
    </context>
    <context id="cref_771508055">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_168762497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aacou:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAt1150PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_509274550">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aacou:ClassAOrdinaryShareParValue00001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_323238395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aacou:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_179077781">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-12</instant>
        </period>
    </context>
    <context id="cref_668387020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-12</instant>
        </period>
    </context>
    <context id="cref_49567198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-12</instant>
        </period>
    </context>
    <context id="cref_1874857369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-12</instant>
        </period>
    </context>
    <context id="cref_1936628900">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
        </entity>
        <period>
            <instant>2025-11-12</instant>
        </period>
    </context>
    <context id="cref_503362297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1927365081">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-13</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <unit id="uref_145379145">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="uref_414420850">
        <measure>pure</measure>
    </unit>
    <unit id="uref_908877115">
        <measure>shares</measure>
    </unit>
    <unit id="uref_138542282">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="uref_1967954440">
        <measure>aacou:Segments</measure>
    </unit>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_129871934"
      id="fc_722877273"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_129871934"
      id="fc_1126925616"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="cref_1701158294"
      id="fc_1834957257"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_179077781"
      id="fc_179077781"
      unitRef="uref_908877115"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_668387020"
      id="fc_668387020"
      unitRef="uref_908877115"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_179077781"
      id="fc_219663813"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_668387020"
      id="fc_2109087212"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_49567198"
      id="fc_49567198"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1874857369"
      id="fc_1874857369"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1936628900"
      id="fc_1936628900"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_503362297"
      id="fc_503362297"
      unitRef="uref_908877115"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_503362297"
      id="fc_597169116"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1927365081"
      id="fc_1927365081"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_2040435108"
      id="fc_536763980"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1927365081"
      id="fc_2078639094"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1601694498"
      id="fc_2074779921"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1284822420"
      id="fc_993907519"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_1021116441"
      id="fc_1908236901"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="cref_1021116441"
      id="fc_1983227818"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_1936628900"
      id="fc_326844248"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_129871934"
      id="fc_1432226560"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_1219919515"
      id="fc_649126349"
      unitRef="uref_908877115"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_1219919515"
      id="fc_1499412547"
      unitRef="uref_908877115"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1701158294"
      id="fc_1306898314"
      unitRef="uref_908877115"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1701158294"
      id="fc_1983493946"
      unitRef="uref_908877115"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_129871934"
      id="fc_931334970"
      unitRef="uref_908877115"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_129871934"
      id="fc_1401394484"
      unitRef="uref_908877115"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1701158294"
      id="fc_1887585116"
      unitRef="uref_908877115"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1701158294"
      id="fc_676698279"
      unitRef="uref_908877115"
      xsi:nil="true"/>
    <aacou:WorkingCapitalLoansOutstanding
      contextRef="cref_129871934"
      id="fc_1964203158"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:Cash
      contextRef="cref_129871934"
      id="fc_2096423442"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration contextRef="cref_32634712" id="fc_419880054">http://fasb.org/srt/2025#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_1021116441"
      id="fc_462739203"
      unitRef="uref_908877115"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="cref_129871934"
      id="fc_1266044112"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="cref_129871934"
      id="fc_1988588703"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="cref_129871934"
      id="fc_2052823349"
      unitRef="uref_145379145"
      xsi:nil="true"/>
    <dei:DocumentFiscalPeriodFocus contextRef="cref_32634712" id="ixv-9470">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="cref_32634712" id="ixv-9471">0002099906</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="cref_32634712" id="ixv-9472">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="cref_32634712" id="ixv-10099">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="cref_32634712" id="ixv-10100">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="cref_32634712" id="ixv-10101">2025-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="cref_32634712" id="ixv-10102">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="cref_32634712" id="ixv-10103">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="cref_32634712" id="ixv-10104">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="cref_32634712" id="ixv-10105">001-43133</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="cref_32634712" id="ixv-10106">ABONY ACQUISITION CORP. I</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="cref_32634712" id="ixv-10107">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="cref_32634712" id="ixv-10108">41-2452803</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="cref_32634712" id="ixv-10109">1700         S Lamar Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="cref_32634712" id="ixv-10110">Suite #338</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="cref_32634712" id="ixv-10111">Austin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="cref_32634712" id="ixv-10112">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="cref_32634712" id="ixv-10113">78704</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="cref_32634712" id="ixv-10114">(512)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="cref_32634712" id="ixv-10115">553-1770</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="cref_323238395" id="ixv-10116">Units,         each consisting of one Class A ordinary share and one-third of one redeemable warrant</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_323238395" id="ixv-10117">AACOU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_323238395" id="ixv-10118">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="cref_509274550" id="ixv-10119">Class         A Ordinary Share, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_509274550" id="ixv-10120">AACO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_509274550" id="ixv-10121">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="cref_168762497" id="ixv-10122">Redeemable         Warrants, each whole warrant exercisable for one Class A ordinary share at $11.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_168762497" id="ixv-10123">AACOW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_168762497" id="ixv-10124">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="cref_32634712" id="ixv-10125">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="cref_32634712" id="ixv-10126">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="cref_32634712" id="ixv-10127">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="cref_32634712" id="ixv-10128">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="cref_32634712" id="ixv-10129">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="cref_32634712" id="ixv-10130">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="cref_32634712" id="ixv-10131">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="cref_32634712" id="ixv-10132">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="cref_32634712" id="ixv-10133">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="cref_32634712" id="ixv-10134">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="cref_32634712" id="ixv-10135">true</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="cref_771508055"
      decimals="0"
      id="ixv-10136"
      unitRef="uref_145379145">0</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_887709007"
      decimals="0"
      id="ixv-10137"
      unitRef="uref_908877115">23695000</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_1237866555"
      decimals="0"
      id="ixv-10138"
      unitRef="uref_908877115">7666667</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="cref_32634712" id="ixv-10139">None</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="cref_32634712" id="ixv-10140">We
are a special purpose acquisition company with no business operations. Since our formation, our sole business activity has been identifying
and evaluating suitable targets for an initial business combination.
Therefore, we do not
consider that we face significant cybersecurity risk and have not adopted any cybersecurity risk management program or formal processes
for assessing, identifying, and managing material risks from cybersecurity threats. Our
board of directors is ultimately responsible for overseeing the risk management activities in general and, as deemed necessary by our
management team, will be informed of any cybersecurity threats or risks that may arise.</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock contextRef="cref_32634712" id="ixv-10141">
Therefore, we do not
consider that we face significant cybersecurity risk and have not adopted any cybersecurity risk management program or formal processes
for assessing, identifying, and managing material risks from cybersecurity threats.</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="cref_32634712" id="ixv-10142">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="cref_32634712" id="ixv-10143">Our
board of directors is ultimately responsible for overseeing the risk management activities in general and, as deemed necessary by our
management team, will be informed of any cybersecurity threats or risks that may arise.</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="cref_32634712" id="ixv-10144">Our
board of directors is ultimately responsible for overseeing the risk management activities in general and, as deemed necessary by our
management team, will be informed of any cybersecurity threats or risks that may arise.</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="cref_32634712" id="ixv-10145">our
management team, will be informed of any cybersecurity threats or risks that may arise.</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="cref_32634712" id="ixv-10146">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="cref_32634712" id="ixv-10147">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="cref_32634712" id="ixv-10148">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="cref_32634712" id="ixv-10149">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="cref_32634712" id="ixv-10150">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <dei:AuditorOpinionTextBlock contextRef="cref_32634712" id="ixv-7173">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Opinion
on the Financial Statements&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
have audited the accompanying balance sheet of Abony Acquisition Corp. I (the &#x201c;Company&#x201d;) as of December 31, 2025, and the
related statements of operations, changes in shareholders&#x2019; deficit, and cash flows for the period from November 13, 2025 (inception)
through December 31, 2025, and the related notes (collectively referred to as the &#x201c;financial statements&#x201d;). In our opinion,
the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025, and
the results of its operations and its cash flows for the period from November 13, 2025 (inception) through December 31, 2025 in conformity
with accounting principles generally accepted in the United States of America.&lt;/span&gt;&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName contextRef="cref_32634712" id="ixv-10151">WithumSmith+Brown, PC</dei:AuditorName>
    <dei:AuditorLocation contextRef="cref_32634712" id="ixv-10152">New York, New York</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="cref_32634712" id="ixv-10153">100</dei:AuditorFirmId>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10154"
      unitRef="uref_145379145">40000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10155"
      unitRef="uref_145379145">40000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredCosts
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10156"
      unitRef="uref_145379145">351275</us-gaap:DeferredCosts>
    <us-gaap:Assets
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10157"
      unitRef="uref_145379145">391275</us-gaap:Assets>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10158"
      unitRef="uref_145379145">33875</us-gaap:AccruedLiabilitiesCurrent>
    <aacou:AccruedOfferingCosts
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10159"
      unitRef="uref_145379145">307325</aacou:AccruedOfferingCosts>
    <aacou:PromissoryNoteRelatedParty
      contextRef="cref_129871934"
      decimals="0"
      id="fc_1765817659"
      unitRef="uref_145379145">124790</aacou:PromissoryNoteRelatedParty>
    <us-gaap:Liabilities
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10161"
      unitRef="uref_145379145">465990</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_129871934"
      decimals="4"
      id="ixv-10162"
      unitRef="uref_138542282">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10163"
      unitRef="uref_908877115">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1701158294"
      decimals="4"
      id="ixv-10164"
      unitRef="uref_138542282">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_1701158294"
      decimals="0"
      id="ixv-10165"
      unitRef="uref_908877115">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_998287359"
      decimals="4"
      id="fc_1278202245"
      unitRef="uref_138542282">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_998287359"
      decimals="0"
      id="fc_381857652"
      unitRef="uref_908877115">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_998287359"
      decimals="0"
      id="fc_1203351570"
      unitRef="uref_908877115">7666667</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_998287359"
      decimals="0"
      id="fc_1884791732"
      unitRef="uref_908877115">7666667</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="cref_998287359"
      decimals="0"
      id="fc_1130686897"
      unitRef="uref_145379145">767</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10171"
      unitRef="uref_145379145">24233</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10172"
      unitRef="uref_145379145">-99715</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10173"
      unitRef="uref_145379145">-74715</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10174"
      unitRef="uref_145379145">391275</us-gaap:LiabilitiesAndStockholdersEquity>
    <aacou:NumberOfOrdinarySharesSubjectToForfeitureIfTheOverallotmentOptionIsNotExercised
      contextRef="cref_998287359"
      decimals="0"
      id="ixv-10175"
      unitRef="uref_908877115">1000000</aacou:NumberOfOrdinarySharesSubjectToForfeitureIfTheOverallotmentOptionIsNotExercised>
    <aacou:NumberOfSharesAreNoLongerSubjectToForfeiture
      contextRef="cref_1198982694"
      decimals="0"
      id="ixv-10176"
      unitRef="uref_908877115">1000000</aacou:NumberOfSharesAreNoLongerSubjectToForfeiture>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10177"
      unitRef="uref_145379145">99715</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10178"
      unitRef="uref_145379145">-99715</us-gaap:OperatingIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10179"
      unitRef="uref_145379145">-99715</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_179795992"
      decimals="0"
      id="fc_333249326"
      unitRef="uref_908877115">6666667</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_179795992"
      decimals="0"
      id="fc_707120496"
      unitRef="uref_908877115">6666667</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_179795992"
      decimals="2"
      id="ixv-10182"
      unitRef="uref_138542282">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_179795992"
      decimals="2"
      id="ixv-10183"
      unitRef="uref_138542282">-0.01</us-gaap:EarningsPerShareDiluted>
    <aacou:NumberOfOrdinarySharesSubjectToForfeitureIfOverallotmentOptionIsNotExercised
      contextRef="cref_992778569"
      decimals="0"
      id="ixv-10185"
      unitRef="uref_908877115">1000000</aacou:NumberOfOrdinarySharesSubjectToForfeitureIfOverallotmentOptionIsNotExercised>
    <aacou:NumberOfOrdinarySharesFullyExercisedTheirOverallotmentOption
      contextRef="cref_1845833247"
      decimals="0"
      id="ixv-10186"
      unitRef="uref_908877115">1000000</aacou:NumberOfOrdinarySharesFullyExercisedTheirOverallotmentOption>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1601694498"
      decimals="0"
      id="fc_865496791"
      unitRef="uref_908877115">7666667</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1601694498"
      decimals="0"
      id="fc_1601694498"
      unitRef="uref_145379145">767</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1284822420"
      decimals="0"
      id="fc_1284822420"
      unitRef="uref_145379145">24233</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1021116441"
      decimals="0"
      id="fc_578705586"
      unitRef="uref_145379145">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="cref_2040435108"
      decimals="0"
      id="ixv-10191"
      unitRef="uref_145379145">-99715</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10192"
      unitRef="uref_145379145">-99715</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_840864601"
      decimals="0"
      id="ixv-10193"
      unitRef="uref_908877115">7666667</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_840864601"
      decimals="0"
      id="ixv-10194"
      unitRef="uref_145379145">767</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1094527778"
      decimals="0"
      id="ixv-10195"
      unitRef="uref_145379145">24233</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1956966180"
      decimals="0"
      id="ixv-10196"
      unitRef="uref_145379145">-99715</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10197"
      unitRef="uref_145379145">-74715</us-gaap:StockholdersEquity>
    <aacou:NumberOfOrdinarySharesSubjectToForfeitureIfOverallotmentOptionIsNotExercised
      contextRef="cref_992778569"
      decimals="0"
      id="ixv-10199"
      unitRef="uref_908877115">1000000</aacou:NumberOfOrdinarySharesSubjectToForfeitureIfOverallotmentOptionIsNotExercised>
    <aacou:NumberOfOrdinarySharesFullyExercisedTheirOverallotmentOption
      contextRef="cref_1845833247"
      decimals="0"
      id="ixv-10200"
      unitRef="uref_908877115">1000000</aacou:NumberOfOrdinarySharesFullyExercisedTheirOverallotmentOption>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10201"
      unitRef="uref_145379145">-99715</us-gaap:NetIncomeLoss>
    <aacou:GeneralAndAdministrativeCostsPaidThroughPromissoryNoteRelatedParty
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10202"
      unitRef="uref_145379145">60840</aacou:GeneralAndAdministrativeCostsPaidThroughPromissoryNoteRelatedParty>
    <aacou:GeneralAndAdministrativeCostsPaidThroughIssuanceOfClassBOrdinaryShares
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10203"
      unitRef="uref_145379145">5000</aacou:GeneralAndAdministrativeCostsPaidThroughIssuanceOfClassBOrdinaryShares>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10204"
      unitRef="uref_145379145">33875</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <aacou:DeferredOfferingCostsIncludedInAccruedOfferingCosts
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10205"
      unitRef="uref_145379145">307325</aacou:DeferredOfferingCostsIncludedInAccruedOfferingCosts>
    <aacou:DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10206"
      unitRef="uref_145379145">43950</aacou:DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty>
    <aacou:PrepaidExpensesPaidThroughPromissoryNoteRelatedParty
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10207"
      unitRef="uref_145379145">20000</aacou:PrepaidExpensesPaidThroughPromissoryNoteRelatedParty>
    <aacou:PrepaidExpensesPaidBySponsorThroughIssuanceOfClassBOrdinaryShares
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10208"
      unitRef="uref_145379145">20000</aacou:PrepaidExpensesPaidBySponsorThroughIssuanceOfClassBOrdinaryShares>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="cref_32634712" id="ixv-8452">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;1
&#x2014;&#160;Organization and Business Operations&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Abony
Acquisition Corp.&#160;I (the &#x201c;Company&#x201d;) is a blank check company incorporated as a Cayman Islands exempted company on November&#160;13,
2025. The Company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition,
share purchase, reorganization or similar business combination with one or more businesses (the &#x201c;Business Combination&#x201d;). The
Company has not selected any specific Business Combination target, and the Company has not, nor has anyone on its behalf, engaged in any
substantive discussions, directly or indirectly, with any Business Combination target with respect to an initial Business Combination
with the Company.&lt;/span&gt; &lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, the Company has not commenced any operations. All activity for the period from November&#160;13,
2025 (inception) through December 31, 2025 relates to the Company&#x2019;s formation, the Initial Public Offering (as defined
below), and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate
any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating
income in the form of interest income on the proceeds derived from the Initial Public Offering (as defined below). The Company has selected
December&#160;31 as its fiscal year end.&lt;/span&gt; &lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s sponsor is Abony Sponsor&#160;I LLC (the &#x201c;Sponsor&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
registration statement for the Company&#x2019;s Initial Public Offering was declared effective on January 30, 2026. On February 20, 2026,
the Company consummated its initial public offering (&#x201c;Initial Public Offering&#x201d;), which consisted of 23,000,000
units (the &#x201c;Units&#x201d;), including the exercise in full by the underwriters of an option to purchase up to 3,000,000
Units at the offering price to cover over-allotments. The Units were sold at a price of $10.00
per Unit, generating gross proceeds to the Company of $230,000,000.&lt;/span&gt;
&lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of 695,000
units (the &#x201c;Private Placement Units&#x201d;) to the Sponsor and BTIG, LLC, the representative of the underwriters, at $10.00
per Unit, generating gross proceeds of $6,950,000.
Of those 695,000
Private Placement Units, the Sponsor purchased 465,000
Private Placement Units and BTIG, LLC purchased 230,000
Private Placement Units.&lt;/span&gt; &lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
Unit will consist of one Class A ordinary share (the &#x201c;Public Shares&#x201d;) and one-third of one redeemable warrant (the &#x201c;Public
Warrants&#x201d;). Each Private Placement Unit will consist of one Class A ordinary share (the &#x201c;Private Placement Share&#x201d;) and
one-third of one redeemable warrant (the &#x201c;Private Placement Warrant&#x201d;). Each whole Public Warrant and Private Placement Warrant
(together the &#x201c;Warrants&#x201d;) entitles the holder to purchase one Class A ordinary share at a price of $11.50
per share.&lt;/span&gt; &lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transaction
costs amounted to $13,314,254,
consisting of $4,600,000
of cash underwriting fee, $8,050,000
of deferred underwriting fee, and $664,254
of other offering costs.&lt;/span&gt; &lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the Private Placement Units, although substantially all of the net proceeds are intended to be generally applied toward consummating
a Business Combination (less deferred underwriting commissions).&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s Business Combination must be with one or more target businesses that together have a fair market value equal to at least
80%
of the net balance in the Trust Account (as defined below) (excluding the amount of deferred underwriting discounts held and taxes payable
on the income earned on the Trust Account) at the time of the signing an agreement to enter into a Business Combination. However, the
Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50%
or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it
not to be required to register as an investment company under the Investment Company Act&#160;of&#160;1940, as amended (the &#x201c;Investment
Company Act&#x201d;). There is no assurance that the Company will be able to successfully effect a Business Combination.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the closing of the Initial Public Offering on February 20, 2026, an amount of $230,000,000
($10.00
per Unit) from the net proceeds of the sale of the Units, and a portion of the net proceeds from the sale of the Private Placement Units,
was held in a trust account (the &#x201c;Trust Account&#x201d;) and initially invested only in U.S.&#160;government treasury obligations
with a maturity of 185&#160;days
or less or in money market funds meeting certain conditions under Rule&#160;2a-7 under the Investment Company Act which invest only in
direct U.S.&#160;government treasury obligations; the holding of these assets in this form is intended to be temporary and for the sole
purpose of facilitating the intended Business Combination. To mitigate the risk that the Company might be deemed to be an investment company
for purposes of the Investment Company Act, which risk increases the longer that the Company holds investments in the Trust Account, the
Company may, at any time (based on the management team&#x2019;s ongoing assessment of all factors related to the Company&#x2019;s potential
status under the Investment Company Act), instruct the trustee to liquidate the investments held in the Trust Account and instead to hold
the funds in the Trust Account in cash or in an interest bearing demand deposit account at a bank. Except with respect to interest earned
on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the Initial Public
Offering and the sale of the Private Placement Units&#160;will not be released from the Trust Account until the earliest of (i)&#160;the
completion of the Company&#x2019;s initial Business Combination, (ii)&#160;the redemption of the Company&#x2019;s Public Shares if the Company
is unable to complete the initial Business Combination within 24&#160;months from the closing of the Initial Public Offering or by such
earlier liquidation date as the Company&#x2019;s board of directors may approve (the &#x201c;Completion Window&#x201d;), subject to applicable
law, or (iii)&#160;the redemption of the Company&#x2019;s Public Shares properly submitted in connection with a shareholder vote to amend
the Company&#x2019;s amended and restated memorandum and articles of association to (A)&#160;modify the substance or timing of the Company&#x2019;s
obligation to allow redemption in connection with the initial Business Combination or to redeem 100%
of the Company&#x2019;s Public Shares if the Company has not consummated an initial Business Combination within the Completion Window or
(B)&#160;with respect to any other material provisions relating to shareholders&#x2019; rights or pre-initial Business Combination activity.
The proceeds deposited in the Trust Account could become subject to the claims of the Company&#x2019;s creditors, if any, which could have
priority over the claims of the Company&#x2019;s public shareholders.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will provide the Company&#x2019;s public shareholders with the opportunity to redeem all or a portion of their Public Shares, regardless
of whether they abstain, vote for, or vote against, an initial Business Combination upon completion of an initial Business Combination
either (i)&#160;in connection with a general meeting called to approve the initial Business Combination or (ii)&#160;without a shareholder
vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business
Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled
to redeem their shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated
as of two&#160;business days prior to the consummation of the initial Business Combination, including interest earned on the funds held
in the Trust Account (less taxes payable), divided by the number of then outstanding Public Shares, subject to the limitations. The amount
in the Trust Account is initially anticipated to be $10.00
per Public Share. The Public Shares are recorded at redemption value and classified as temporary equity upon the completion of the Initial
Public Offering, in accordance with Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;)
Topic&#160;480, &#x201c;Distinguishing Liabilities from Equity.&#x201d;&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has only the duration of the Completion Window to complete the initial Business Combination. However, if the Company is unable
to complete its initial Business Combination within the Completion Window, the Company will as promptly as reasonably possible but not
more than ten&#160;business days thereafter (and subject to lawfully available funds therefor), redeem the Public Shares, at a per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held
in the Trust Account (which interest shall be net of taxes and less up to $100,000
of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will constitute full
and complete payment for the Public Shares and completely extinguish public shareholders&#x2019; rights as shareholders (including the
right to receive further liquidation or other distributions, if any), subject to the Company&#x2019;s obligations under Cayman Islands
law to provide for claims of creditors and subject to the other requirements of applicable law.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor, officers and directors (&#x201c;Initial Shareholders&#x201d;) entered into a letter agreement with the Company, pursuant to which
they agree to waive their redemption rights with respect to any shares held by them in connection with the completion of an initial Business
Combination. Additionally, the Sponsor, officers and directors will agree to waive their rights to liquidating distributions from the
Trust Account with respect to their founder shares and Private Placement Shares if the Company fails to complete an initial Business Combination
within the prescribed time frame, although they will be entitled to liquidating distributions from assets outside the Trust Account. If
the Company does not complete the initial Business Combination within the prescribed time frame, the Private Placement Units&#160;(and
the securities comprising such units) will be worthless. Furthermore, the initial shareholders will agree not to transfer, assign or sell
any of their founder shares and any Class&#160;A ordinary shares issuable upon conversion thereof until the earlier to occur of (i)&#160;six
months after the completion of the initial Business Combination or (ii)&#160;the date following the completion of the initial Business
Combination on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the
shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing,
(1)&#160;if the closing price of the Class&#160;A ordinary shares equals or exceeds $12.00
per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20&#160;trading
days within any 30-trading&#160;day
period commencing at least 30&#160;days
after the initial Business Combination or (2)&#160;if the Company consummates a transaction after the initial Business Combination which
results in our shareholders having the right to exchange their shares for cash, securities or other property, the founder shares will
be released from the lock-up. The Private Placement Units&#160;(including the securities comprising such units and the Class&#160;A ordinary
shares issuable upon exercise of the Private Placement Warrants) will not be transferable until 30&#160;days following the completion
of the initial Business Combination. Because each of the officers and directors will own ordinary shares or units directly or indirectly,
they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate
the initial Business Combination.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s Sponsor agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered
or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent,
confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below
the lesser of (i)&#160;$10.00
per Public Share and (ii)&#160;the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust
Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability
will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies
held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#x2019;s indemnity
of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act&#160;of&#160;1933,
as amended (the &#x201c;Securities Act&#x201d;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations,
nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company
believes that the Sponsor&#x2019;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would
be able to satisfy those obligations.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Liquidity,
Capital Resources and Going Concern&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s liquidity needs up to December 31, 2025 were satisfied through the loan under an unsecured promissory note from the Sponsor
of up to $400,000
(see Note 5). As of December 31, 2025, the Company had &lt;span style="-sec-ix-hidden:fc_2096423442"&gt;no&lt;/span&gt; cash and working capital deficit
of $425,990.&lt;/span&gt;
&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of
the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working Capital
Loans&#x201d;). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business
Combination, without interest, or, at the lender&#x2019;s discretion, up to $1,500,000
of the Working Capital Loans may be converted upon completion of a Business Combination into private units at a price of $10.00
per unit. Such private units would be identical to the Private Placement Units. In the event that a Business Combination does not close,
the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the
Trust Account would be used to repay the Working Capital Loans. As of December 31, 2025, there were no Working Capital Loans outstanding.&lt;/span&gt;
&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Company&#x2019;s assessment of going concern considerations in accordance with FASB ASC 205-40, &#x201c;Presentation
of Financial Statements - Going Concern,&#x201d; the Company does not believe it will need to raise additional funds in order to meet the
expenditures required for operating its business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;However,
if the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination
are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to
the initial Business Combination. The Company has the Completion Window to complete the initial Business Combination. Management has determined
that after the Initial Public Offering closed on February 20, 2026, the Company has sufficient funds to finance the working capital needs
of the Company within one year from the date of issuance of the financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <dei:EntityIncorporationDateOfIncorporation contextRef="cref_1021116441" id="ixv-10209">2025-11-13</dei:EntityIncorporationDateOfIncorporation>
    <aacou:YearOfInception contextRef="cref_1021116441" id="ixv-10210">November&#160;13,
2025 (inception) through December 31, 2025</aacou:YearOfInception>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_138542282"
      decimals="0"
      id="ixv-10211"
      unitRef="uref_908877115">23000000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_1538738852"
      decimals="0"
      id="ixv-10212"
      unitRef="uref_908877115">3000000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <aacou:NumberOfUnitsSoldPricePerUnit
      contextRef="cref_138542282"
      decimals="2"
      id="ixv-10213"
      unitRef="uref_138542282">10</aacou:NumberOfUnitsSoldPricePerUnit>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_414420850"
      decimals="0"
      id="ixv-10214"
      unitRef="uref_145379145">230000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_639467079"
      decimals="0"
      id="ixv-10215"
      unitRef="uref_908877115">695000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <aacou:NumberOfUnitsSoldPricePerUnit
      contextRef="cref_639467079"
      decimals="2"
      id="ixv-10216"
      unitRef="uref_138542282">10</aacou:NumberOfUnitsSoldPricePerUnit>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_1295773837"
      decimals="0"
      id="ixv-10217"
      unitRef="uref_145379145">6950000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_639467079"
      decimals="0"
      id="ixv-10218"
      unitRef="uref_908877115">695000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_873881575"
      decimals="0"
      id="ixv-10219"
      unitRef="uref_908877115">465000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_533141458"
      decimals="0"
      id="ixv-10220"
      unitRef="uref_908877115">230000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1142121933"
      decimals="2"
      id="ixv-10221"
      unitRef="uref_138542282">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <aacou:TransactionCosts
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10222"
      unitRef="uref_145379145">13314254</aacou:TransactionCosts>
    <aacou:CashUnderwritingFee
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10223"
      unitRef="uref_145379145">4600000</aacou:CashUnderwritingFee>
    <aacou:DeferredUnderwritingFee
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10224"
      unitRef="uref_145379145">8050000</aacou:DeferredUnderwritingFee>
    <aacou:OtherOfferingCosts
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10225"
      unitRef="uref_145379145">664254</aacou:OtherOfferingCosts>
    <aacou:PercentageOfFairMarketValueNetAssetsHeldInTrustAccount
      contextRef="cref_1021116441"
      decimals="2"
      id="ixv-10226"
      unitRef="uref_414420850">0.80</aacou:PercentageOfFairMarketValueNetAssetsHeldInTrustAccount>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="cref_695008509"
      decimals="2"
      id="ixv-10227"
      unitRef="uref_414420850">0.50</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_414420850"
      decimals="0"
      id="ixv-10228"
      unitRef="uref_145379145">230000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <aacou:NumberOfUnitsSoldPricePerUnit
      contextRef="cref_138542282"
      decimals="2"
      id="ixv-10229"
      unitRef="uref_138542282">10</aacou:NumberOfUnitsSoldPricePerUnit>
    <aacou:InvestmentMaturityTerm contextRef="cref_2007673822" id="ixv-10230">P185D</aacou:InvestmentMaturityTerm>
    <aacou:PercentageOfRedemptionOnPublicShares
      contextRef="cref_695008509"
      decimals="2"
      id="ixv-10231"
      unitRef="uref_414420850">1</aacou:PercentageOfRedemptionOnPublicShares>
    <aacou:PricePerSharesOfPublicShare
      contextRef="cref_129871934"
      decimals="2"
      id="ixv-10232"
      unitRef="uref_138542282">10</aacou:PricePerSharesOfPublicShare>
    <aacou:MinimumAmountPaymentForDissolutionExpenses
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10233"
      unitRef="uref_145379145">100000</aacou:MinimumAmountPaymentForDissolutionExpenses>
    <aacou:ClosingPriceOfOrdinaryShareEqualOrExceed
      contextRef="cref_1701158294"
      decimals="2"
      id="ixv-10234"
      unitRef="uref_138542282">12</aacou:ClosingPriceOfOrdinaryShareEqualOrExceed>
    <aacou:TradingDay contextRef="cref_565461537" id="ixv-10235">P20D</aacou:TradingDay>
    <aacou:TradingDay contextRef="cref_1021116441" id="ixv-10236">P30D</aacou:TradingDay>
    <aacou:TradingDay contextRef="cref_1021116441" id="ixv-10237">P30D</aacou:TradingDay>
    <aacou:PricePerSharesOfPublicShare
      contextRef="cref_129871934"
      decimals="2"
      id="ixv-10238"
      unitRef="uref_138542282">10</aacou:PricePerSharesOfPublicShare>
    <us-gaap:UnsecuredDebt
      contextRef="cref_2079974558"
      decimals="0"
      id="ixv-10239"
      unitRef="uref_145379145">400000</us-gaap:UnsecuredDebt>
    <aacou:WorkingCapitalDeficit
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10240"
      unitRef="uref_145379145">425990</aacou:WorkingCapitalDeficit>
    <aacou:WorkingCapitalLoans
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10241"
      unitRef="uref_145379145">1500000</aacou:WorkingCapitalLoans>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="cref_301617889"
      decimals="2"
      id="ixv-10242"
      unitRef="uref_138542282">10</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="cref_32634712" id="ixv-8598">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;2
&#x2014;&#160;Significant Accounting Policies&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Basis
of Presentation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United&#160;States
of America (&#x201c;U.S.&#160;GAAP&#x201d;) and pursuant to the rules and regulations of the United&#160;States Securities and Exchange
Commission (the &#x201c;SEC&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Emerging
Growth Company Status&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart
Our Business Startups Act&#160;of&#160;2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various
reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited
to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding
a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial
accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the
requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not
to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application
dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private
companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public
company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition
period difficult or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment.
It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the
date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or
more future confirming events. Accordingly, the actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had &lt;span style="-sec-ix-hidden:fc_2052823349"&gt;no&lt;/span&gt; cash or cash equivalents as of December 31, 2025.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000.
Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition,
results of operations, and cash flows.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Deferred
Offering Costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with the requirements of the FASB ASC&#160;340-10-S99 and SEC Staff Accounting Bulletin Topic&#160;5A, &#x201c;Expenses
of Offering.&#x201d; Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering.
FASB ASC&#160;470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of
convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from
the Units&#160;between Class&#160;A ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds
first to assigned value of the warrants included in the Units&#160;and then to the Class&#160;A ordinary shares. Offering costs allocated
to the Public Shares were charged to temporary equity. Offering costs allocated to the Public Warrants and the Private Placement Units&#160;were
charged to shareholder&#x2019;s deficit as the underlying financial instruments, after management&#x2019;s evaluation, were classified within
shareholder&#x2019;s deficit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under FASB ASC&#160;820, &#x201c;Fair
Value Measurements and Disclosures,&#x201d; approximate the carrying amounts represented in the balance sheet, primarily due to their short-term
nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction
between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 1, defined as observable inputs
        such as quoted prices (unadjusted) for identical instruments in active markets;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 2, defined as inputs other than
        quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active
        markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level&#160;3, defined as unobservable
        inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived
        from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Net
Loss per Class&#160;B Ordinary Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
loss per Class&#160;B ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during
the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 1,000,000
ordinary shares that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (see Note&#160;7). At
December 31, 2025, the Company did &lt;span style="-sec-ix-hidden:fc_462739203"&gt;no&lt;/span&gt;t have any dilutive securities and other contracts
that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted
loss per Class&#160;B ordinary share is the same as basic loss per Class&#160;B ordinary share for the period presented.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Income
Taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes under FASB ASC Topic&#160;740, &#x201c;Income Taxes,&#x201d; which requires an asset and liability approach
to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between
the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted
tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are
established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FASB
ASC Topic&#160;740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement
of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely
than not to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the Cayman Islands is
the Company&#x2019;s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. As of December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_1266044112"&gt;no&lt;/span&gt; unrecognized tax benefits
and &lt;span style="-sec-ix-hidden:fc_1988588703"&gt;no&lt;/span&gt; amounts accrued for interest and penalties. The Company is currently not aware
of any issues under review that could result in significant payments, accruals or material deviation from its position.&lt;/span&gt; &lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is considered to be a Cayman Islands exempted company with no connection to any other taxable jurisdiction and is presently not
subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States. As such, the Company&#x2019;s
tax provision was zero
for the period presented.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Share-Based
Compensation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for share awards in accordance with FASB ASC Topic 718, &#x201c;Compensation&#x2014;Stock Compensation,&#x201d; which requires
that all equity awards be accounted for at their &#x201c;fair value.&#x201d; Fair value is measured on the grant date and is equal to the
underlying value of the share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Costs
equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to
vest, in the period of grant for awards that vest immediately and have no future service condition, or in the period the awards vest immediately
after meeting a performance condition becomes probable (e.g., the occurrence of Initial Public Offering). For awards that vest over time,
cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company&#x2019;s initial estimates;
previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Warrant
Instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for the Public Warrants and Private Placement Warrants issued in connection with the Initial Public Offering and the
private placement in accordance with the guidance contained in FASB ASC Topic&#160;815, &#x201c;Derivatives and Hedging&#x201d;. Accordingly,
the Company evaluated and classified the warrant instruments under equity treatment at their relative fair values.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November&#160;2023, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;)&#160;2023-07, &#x201c;Segment Reporting (Topic&#160;280):
Improvements to Reportable Segment Disclosures&#x201d; (&#x201c;ASU&#160;2023-07&#x201d;). The amendments in this ASU require disclosures,
on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker (&#x201c;CODM&#x201d;),
as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that
a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s)&#160;of segment
profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all
annual disclosures currently required by Topic&#160;280 in interim periods, and entities with a single reportable segment are required
to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic&#160;280. The ASU is effective
for fiscal&#160;years beginning after December&#160;15, 2023, and interim periods within fiscal&#160;years beginning after December&#160;15,
2024, with early adoption permitted. The Company adopted ASU&#160;2023-07 on November&#160;13, 2025, the date of its incorporation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December&#160;2023, the FASB issued ASU&#160;2023-09, &#x201c;Income Taxes (ASC Topic&#160;740): Improvements to Income Tax Disclosures&#x201d;
(ASU&#160;2023-09), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures
of income taxes paid, among other disclosure requirements. ASU&#160;2023-09 is effective for annual reporting periods beginning after
December&#160;15, 2024 for public business entities. Early adoption is permitted. The Company&#x2019;s management does not believe the
adoption of ASU&#160;2023-09 will have a material impact on its financial statements and disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material
effect on the accompanying financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="cref_32634712" id="ixv-8605">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Basis
of Presentation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United&#160;States
of America (&#x201c;U.S.&#160;GAAP&#x201d;) and pursuant to the rules and regulations of the United&#160;States Securities and Exchange
Commission (the &#x201c;SEC&#x201d;).&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <aacou:EmergingGrowthCompanyStatusPolicyTextBlock contextRef="cref_32634712" id="ixv-8616">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Emerging
Growth Company Status&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart
Our Business Startups Act&#160;of&#160;2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various
reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited
to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding
a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial
accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the
requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not
to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application
dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private
companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public
company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition
period difficult or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;</aacou:EmergingGrowthCompanyStatusPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="cref_32634712" id="ixv-8653">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment.
It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the
date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or
more future confirming events. Accordingly, the actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="cref_32634712" id="ixv-8664">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had &lt;span style="-sec-ix-hidden:fc_2052823349"&gt;no&lt;/span&gt; cash or cash equivalents as of December 31, 2025.&lt;/span&gt; &lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="cref_32634712" id="ixv-8676">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000.
Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition,
results of operations, and cash flows.&lt;/span&gt; &lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10243"
      unitRef="uref_145379145">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="cref_32634712" id="ixv-8686">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Deferred
Offering Costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with the requirements of the FASB ASC&#160;340-10-S99 and SEC Staff Accounting Bulletin Topic&#160;5A, &#x201c;Expenses
of Offering.&#x201d; Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering.
FASB ASC&#160;470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of
convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from
the Units&#160;between Class&#160;A ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds
first to assigned value of the warrants included in the Units&#160;and then to the Class&#160;A ordinary shares. Offering costs allocated
to the Public Shares were charged to temporary equity. Offering costs allocated to the Public Warrants and the Private Placement Units&#160;were
charged to shareholder&#x2019;s deficit as the underlying financial instruments, after management&#x2019;s evaluation, were classified within
shareholder&#x2019;s deficit.&lt;/span&gt;&lt;/p&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="cref_32634712" id="ixv-8697">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under FASB ASC&#160;820, &#x201c;Fair
Value Measurements and Disclosures,&#x201d; approximate the carrying amounts represented in the balance sheet, primarily due to their short-term
nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction
between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 1, defined as observable inputs
        such as quoted prices (unadjusted) for identical instruments in active markets;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 2, defined as inputs other than
        quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active
        markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level&#160;3, defined as unobservable
        inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived
        from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="cref_32634712" id="ixv-8760">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Net
Loss per Class&#160;B Ordinary Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
loss per Class&#160;B ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during
the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 1,000,000
ordinary shares that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (see Note&#160;7). At
December 31, 2025, the Company did &lt;span style="-sec-ix-hidden:fc_462739203"&gt;no&lt;/span&gt;t have any dilutive securities and other contracts
that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted
loss per Class&#160;B ordinary share is the same as basic loss per Class&#160;B ordinary share for the period presented.&lt;/span&gt; &lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <aacou:NumberOfSharesSubjectToForfeitureIfOverAllotmentOptionIsNotExercisedByUnderwriters
      contextRef="cref_179795992"
      decimals="0"
      id="ixv-10244"
      unitRef="uref_908877115">1000000</aacou:NumberOfSharesSubjectToForfeitureIfOverAllotmentOptionIsNotExercisedByUnderwriters>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="cref_32634712" id="ixv-8771">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Income
Taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes under FASB ASC Topic&#160;740, &#x201c;Income Taxes,&#x201d; which requires an asset and liability approach
to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between
the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted
tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are
established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FASB
ASC Topic&#160;740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement
of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely
than not to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the Cayman Islands is
the Company&#x2019;s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. As of December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_1266044112"&gt;no&lt;/span&gt; unrecognized tax benefits
and &lt;span style="-sec-ix-hidden:fc_1988588703"&gt;no&lt;/span&gt; amounts accrued for interest and penalties. The Company is currently not aware
of any issues under review that could result in significant payments, accruals or material deviation from its position.&lt;/span&gt; &lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is considered to be a Cayman Islands exempted company with no connection to any other taxable jurisdiction and is presently not
subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States. As such, the Company&#x2019;s
tax provision was zero
for the period presented.&lt;/span&gt; &lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10245"
      unitRef="uref_145379145">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="cref_32634712" id="ixv-8812">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Share-Based
Compensation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for share awards in accordance with FASB ASC Topic 718, &#x201c;Compensation&#x2014;Stock Compensation,&#x201d; which requires
that all equity awards be accounted for at their &#x201c;fair value.&#x201d; Fair value is measured on the grant date and is equal to the
underlying value of the share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Costs
equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to
vest, in the period of grant for awards that vest immediately and have no future service condition, or in the period the awards vest immediately
after meeting a performance condition becomes probable (e.g., the occurrence of Initial Public Offering). For awards that vest over time,
cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company&#x2019;s initial estimates;
previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited.&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <aacou:WarrantInstrumentsPolicyTextBlock contextRef="cref_32634712" id="ixv-8827">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Warrant
Instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for the Public Warrants and Private Placement Warrants issued in connection with the Initial Public Offering and the
private placement in accordance with the guidance contained in FASB ASC Topic&#160;815, &#x201c;Derivatives and Hedging&#x201d;. Accordingly,
the Company evaluated and classified the warrant instruments under equity treatment at their relative fair values.&lt;/span&gt;&lt;/p&gt;</aacou:WarrantInstrumentsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="cref_32634712" id="ixv-8837">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November&#160;2023, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;)&#160;2023-07, &#x201c;Segment Reporting (Topic&#160;280):
Improvements to Reportable Segment Disclosures&#x201d; (&#x201c;ASU&#160;2023-07&#x201d;). The amendments in this ASU require disclosures,
on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker (&#x201c;CODM&#x201d;),
as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that
a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s)&#160;of segment
profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all
annual disclosures currently required by Topic&#160;280 in interim periods, and entities with a single reportable segment are required
to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic&#160;280. The ASU is effective
for fiscal&#160;years beginning after December&#160;15, 2023, and interim periods within fiscal&#160;years beginning after December&#160;15,
2024, with early adoption permitted. The Company adopted ASU&#160;2023-07 on November&#160;13, 2025, the date of its incorporation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December&#160;2023, the FASB issued ASU&#160;2023-09, &#x201c;Income Taxes (ASC Topic&#160;740): Improvements to Income Tax Disclosures&#x201d;
(ASU&#160;2023-09), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures
of income taxes paid, among other disclosure requirements. ASU&#160;2023-09 is effective for annual reporting periods beginning after
December&#160;15, 2024 for public business entities. Early adoption is permitted. The Company&#x2019;s management does not believe the
adoption of ASU&#160;2023-09 will have a material impact on its financial statements and disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material
effect on the accompanying financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <aacou:InitialPublicOfferingTextBlock contextRef="cref_32634712" id="ixv-8873">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;3
&#x2014;&#160;Initial Public Offering&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the closing of the Initial Public Offering, the Company sold 23,000,000&#160;Units&#160;
at a purchase price of $10.00
per Unit. Each Unit has a price of $10.00
and consists of one Class&#160;A ordinary share, and one-third of one redeemable Public Warrant. Each whole Public Warrant entitles the
holder to purchase one Class&#160;A ordinary share at a price of $11.50
per share, subject to adjustment. Each Public Warrant will become exercisable 30&#160;days
after the completion of the initial Business Combination and will expire five&#160;years after the completion of the initial Business
Combination, or earlier upon redemption or liquidation.&lt;/span&gt; &lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Warrants&#160;&#x2014;&lt;/span&gt;&#160;There
were no Public Warrants and Private Warrants issued or outstanding as of December 31, 2025. Each whole Warrant entitles the holder to
purchase one Class&#160;A ordinary share at a price of $11.50
per share, subject to adjustment as discussed herein. The Warrants cannot be exercised until 30&#160;days
after the completion of the initial Business Combination, and will expire at 5:00&#160;p.m., New&#160;York City time, five&#160;years
after the completion of the initial Business Combination or earlier upon redemption or liquidation.&lt;/span&gt; &lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will not be obligated to deliver any Class&#160;A ordinary shares pursuant to the exercise of a Warrant and will have no obligation
to settle such Warrant exercise unless a registration statement on Form S-1, Form S-3, Form F-1, or Form F-3, as applicable, under the
Securities Act with respect to the Class&#160;A ordinary shares underlying the Warrants is then effective and a prospectus relating thereto
is current. No Warrant will be exercisable and the Company will not be obligated to issue a Class&#160;A ordinary share upon exercise
of a Warrant unless the Class&#160;A ordinary share issuable upon such Warrant exercise has been registered, qualified or deemed to be
exempt under the securities laws of the state of residence of the registered holder of the Warrants. In the event that the conditions
in the two immediately preceding sentences are not satisfied with respect to a Warrant, the holder of such Warrant will not be entitled
to exercise such Warrant and such Warrant may have no value and expire worthless. In no event will the Company be required to net cash
settle any Warrant. In the event that a registration statement on Form S-1, Form S-3, Form F-1, or Form F-3, as applicable, is not effective
for the exercised Warrants, the purchaser of a Unit containing such Warrant will have paid the full purchase price for the Unit solely
for the Class&#160;A ordinary share underlying such Unit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the terms of the warrant agreement, the Company will agree that, as soon as practicable, but in no event later than 20&#160;business
days after the closing of its Business Combination, it will use commercially reasonable efforts to file with the SEC a post-effective
amendment to the registration statement for the Initial Public Offering or a new registration statement on Form S-1, Form S-3, Form F-1,
or Form F-3, as applicable, covering the registration under the Securities Act&#160;of&#160;the Class&#160;A ordinary shares issuable
upon exercise of the Warrants and thereafter will use its commercially reasonable efforts to cause the same to become effective within
60&#160;business
days following the Company&#x2019;s initial Business Combination and to maintain a current prospectus relating to the Class&#160;A ordinary
shares issuable upon exercise of the Warrants until the expiration of the Warrants in accordance with the provisions of the warrant agreement.
If a registration statement on Form S-1, Form S-3, Form F-1, or Form F-3, as applicable, covering the Class&#160;A ordinary shares issuable
upon exercise of the Warrants is not effective by the sixtieth (60&lt;sup&gt;th&lt;/sup&gt;) business&#160;day after the closing of the initial Business
Combination, Warrant holders may, until such time as there is an effective registration statement and during any period when the Company
will have failed to maintain an effective registration statement, exercise Warrants on a &#x201c;cashless basis&#x201d; in accordance with
Section&#160;3(a)(9)&#160;of the Securities Act or another exemption. Notwithstanding the above, if the Class&#160;A ordinary shares are
at the time of any exercise of a Warrant not listed on a national securities exchange such that they satisfy the definition of a &#x201c;covered
security&#x201d; under Section&#160;18(b)(1)&#160;of the Securities Act, the Company may, at its option, require holders of Public Warrants
who exercise their warrants to do so on a &#x201c;cashless basis&#x201d; in accordance with Section&#160;3(a)(9)&#160;of the Securities
Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement,
and in the event the Company does not so elect, the Company will use its commercially reasonable efforts to register or qualify the shares
under applicable blue sky laws to the extent an exemption is not available.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the holders exercise their Public Warrants on a cashless basis, they would pay the warrant exercise price by surrendering the warrants
for that number of Class&#160;A ordinary shares equal to the quotient obtained by dividing (x)&#160;the product of the number of Class&#160;A
ordinary shares underlying the warrants, multiplied by the excess of the &#x201c;fair market value&#x201d; of the Class&#160;A ordinary
shares over the exercise price of the warrants by (y)&#160;the fair market value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
&#x201c;fair market value&#x201d; is the average reported closing price of the Class&#160;A ordinary shares for the 10&#160;trading
days ending on the third&#160;trading day prior to the date on which the notice of exercise is received by the warrant agent or on which
the notice of redemption is sent to the holders of warrants, as applicable.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Redemption
of Warrants When the Price per Class&#160;A Ordinary Share Equals or Exceeds $18.00&lt;/i&gt;:
The Company may redeem the outstanding Warrants:&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.85pt; text-indent: -19.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in whole and not in part;&lt;/span&gt;&lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.85pt; text-indent: -19.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at a price of $0.01
        per Warrant;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.85pt; text-indent: -19.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon a minimum of 30&#160;days&#x2019;
        prior written notice of redemption (the &#x201c;30-day
        redemption period&#x201d;); and&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.85pt; text-indent: -19.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if, and only if, the closing price
        of the Class&#160;A ordinary shares equals or exceeds $18.00
        per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a Warrant) for any 20&#160;trading
        days within a 30-trading&#160;day
        period commencing at least 30&#160;days
        after completion of the Company&#x2019;s initial Business Combination and ending three&#160;business days before the Company sends the
        notice of redemption to the Warrant holders.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additionally,
if the number of outstanding Class&#160;A ordinary shares is increased by a share capitalization payable in Class&#160;A ordinary shares,
or by a subdivision of ordinary shares or other similar event, then, on the effective date of such share capitalization, subdivision or
similar event, the number of Class&#160;A ordinary shares issuable on exercise of each Warrant will be increased in proportion to such
increase in the outstanding ordinary shares. A rights offering made to all or substantially all holders of ordinary shares entitling holders
to purchase Class&#160;A ordinary shares at a price less than the fair market value will be deemed a share capitalization of a number
of Class&#160;A ordinary shares equal to the product of (i)&#160;the number of Class&#160;A ordinary shares actually sold in such rights
offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Class&#160;A
ordinary shares) and (ii)&#160;the quotient of (x)&#160;the price per Class&#160;A ordinary share paid in such rights offering and (y)&#160;the
fair market value. For these purposes (i)&#160;if the rights offering is for securities convertible into or exercisable for Class&#160;A
ordinary shares, in determining the price payable for Class&#160;A ordinary shares, there will be taken into account any consideration
received for such rights, as well as any additional amount payable upon exercise or conversion and (ii)&#160;fair market value means the
volume weighted average price of Class&#160;A ordinary shares as reported during the ten (10)&#160;trading&#160;day
period ending on the&#160;trading day prior to the first date on which the Class&#160;A ordinary shares trade on the applicable exchange
or in the applicable market, regular way, without the right to receive such rights.&lt;/span&gt; &lt;/p&gt;</aacou:InitialPublicOfferingTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_414420850"
      decimals="0"
      id="ixv-10246"
      unitRef="uref_908877115">23000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1845149687"
      decimals="2"
      id="ixv-10247"
      unitRef="uref_138542282">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_2134791791"
      decimals="2"
      id="ixv-10248"
      unitRef="uref_138542282">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_678862350"
      decimals="2"
      id="ixv-10249"
      unitRef="uref_138542282">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <aacou:NumberOfDaysAfterCompletionInitialBusinessCombination contextRef="cref_414420850" id="ixv-10250">P30D</aacou:NumberOfDaysAfterCompletionInitialBusinessCombination>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1142121933"
      decimals="2"
      id="ixv-10251"
      unitRef="uref_138542282">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <aacou:NumberOfDaysAfterCompletionInitialBusinessCombination contextRef="cref_551561350" id="ixv-10252">P30Y</aacou:NumberOfDaysAfterCompletionInitialBusinessCombination>
    <aacou:PeriodToFileRegistrationStatementAfterInitialBusinessCombination contextRef="cref_1021116441" id="ixv-10253">P20D</aacou:PeriodToFileRegistrationStatementAfterInitialBusinessCombination>
    <aacou:PeriodForRegistrationStatementToBecomeEffective contextRef="cref_1021116441" id="ixv-10254">P60D</aacou:PeriodForRegistrationStatementToBecomeEffective>
    <aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays contextRef="cref_1634986019" id="ixv-10255">P10D</aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1701158294"
      decimals="2"
      id="ixv-10256"
      unitRef="uref_138542282">18</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <aacou:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRight
      contextRef="cref_1021116441"
      decimals="2"
      id="ixv-10257"
      unitRef="uref_138542282">0.01</aacou:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRight>
    <aacou:PriorWrittenNoticeOfRedemption contextRef="cref_1021116441" id="ixv-10258">P30D</aacou:PriorWrittenNoticeOfRedemption>
    <aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays contextRef="cref_1021116441" id="ixv-10259">P30D</aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
    <aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightStockPriceTrigger
      contextRef="cref_1021116441"
      decimals="2"
      id="ixv-10260"
      unitRef="uref_138542282">18</aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightStockPriceTrigger>
    <aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays contextRef="cref_1021116441" id="ixv-10261">P20D</aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays>
    <aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays contextRef="cref_1021116441" id="ixv-10262">P30D</aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
    <aacou:ExercisableAfterTheCompletionOfTheInitialBusinessCombination contextRef="cref_1021116441" id="ixv-10263">P30D</aacou:ExercisableAfterTheCompletionOfTheInitialBusinessCombination>
    <aacou:TradingDays contextRef="cref_1021116441" id="fc_1074879386">P10D</aacou:TradingDays>
    <aacou:PrivatePlacementTextBlock contextRef="cref_32634712" id="ixv-8976">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;4
&#x2014;&#160;Private Placement&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the Initial Public Offering, the Sponsor and the underwriters purchased an aggregate of 695,000
Private Placement Units, at a price of $10.00
per Private Placement Unit, or $6,950,000.
Of those 695,000
Private Placement Units, the Sponsor purchased 465,000
Private Placement Units and BTIG, LLC purchased 230,000
Private Placement Units. Each Private Placement Unit consists of one Class&#160;A ordinary share and one-third of one redeemable warrant.
Each whole Private Placement Warrant entitles the registered holder to purchase one Class&#160;A ordinary share at a price of $11.50
per share, subject to adjustment.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Private Placement Warrants are identical to the Public Warrants sold in the Initial Public Offering except that, so long as they are held
by the Sponsor, BTIG, LLC, or their permitted transferees, the Private Placement Warrants (i)&#160;may not (including the Class&#160;A
ordinary shares issuable upon exercise of these Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned
or sold by the holders until 30&#160;days
after the completion of the initial Business Combination, (ii)&#160;will be entitled to registration rights and (iii)&#160;with respect
to Private Placement Warrants held by BTIG, LLC and/or its designees, will not be exercisable more than five&#160;years from the commencement
of sales in the Initial Public Offering in accordance with Financial Industry Regulatory Authority Rule&#160;5110(g)(8).&lt;/span&gt; &lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor, officers and directors entered into a letter agreement with the Company, pursuant to which they will agree to (i)&#160;waive
their redemption rights with respect to any shares held by them in connection with the completion of the initial Business Combination;
(ii)&#160;waive their redemption rights with respect to any shares held by them in connection with a shareholder vote to approve an amendment
to the amended and restated memorandum and articles of association (A)&#160;to modify the substance or timing of the Company&#x2019;s obligation
to allow redemption in connection with the initial Business Combination or to redeem 100%
of the Public Shares if the Company has not consummated an initial Business Combination within the Completion Window or (B)&#160;with
respect to any other material provisions relating to shareholders&#x2019; rights or pre-initial Business Combination activity; (iii)&#160;waive
their rights to liquidating distributions from the Trust Account with respect to their founder shares and Private Placement Shares if
the Company fails to complete an initial Business Combination within the Completion Window, although they will be entitled to liquidating
distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete an initial Business
Combination within the prescribed time frame and to liquidating distributions from assets outside the Trust Account; and (iv)&#160;vote
any founder shares and Private Placement Shares held by them and any Public Shares purchased during or after the Initial Public Offering
(including in open market and privately negotiated transactions, aside from shares they may purchase in compliance with the requirements
of Rule&#160;14e-5 under the Exchange&#160;Act, which would not be voted in favor of approving the Business Combination transaction) in
favor of the initial Business Combination.&lt;/span&gt; &lt;/p&gt;</aacou:PrivatePlacementTextBlock>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_639467079"
      decimals="0"
      id="ixv-10265"
      unitRef="uref_908877115">695000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <aacou:NumberOfUnitsSoldPricePerUnit
      contextRef="cref_2084948506"
      decimals="2"
      id="ixv-10266"
      unitRef="uref_138542282">10</aacou:NumberOfUnitsSoldPricePerUnit>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_542702771"
      decimals="0"
      id="ixv-10267"
      unitRef="uref_145379145">6950000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_972287698"
      decimals="0"
      id="ixv-10268"
      unitRef="uref_908877115">695000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_2084948506"
      decimals="0"
      id="ixv-10269"
      unitRef="uref_908877115">465000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_1197005563"
      decimals="0"
      id="ixv-10270"
      unitRef="uref_908877115">230000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_972287698"
      decimals="2"
      id="ixv-10271"
      unitRef="uref_138542282">11.5</us-gaap:SaleOfStockPricePerShare>
    <aacou:NumberOfDaysAfterCompletionOfInitialBusinessCombination
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10272"
      unitRef="uref_145379145">30</aacou:NumberOfDaysAfterCompletionOfInitialBusinessCombination>
    <aacou:PercentageRedeemablePublicShares
      contextRef="cref_1021116441"
      decimals="2"
      id="ixv-10273"
      unitRef="uref_414420850">1</aacou:PercentageRedeemablePublicShares>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="cref_32634712" id="ixv-9015">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;5
&#x2014;&#160;Related Party Transaction&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Founder
Shares&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November&#160;28, 2025, the Initial Shareholders made capital contributions of $25,000
in the aggregate, or approximately $0.003
per share, to cover certain of the Company&#x2019;s expenses, for which the Company issued 5,750,000
founder shares to the Initial Shareholders. On December 16,&#160;2025, the Company issued additional 1,916,667
founder shares through a share capitalization resulting in the Sponsor holding 7,666,667
founder shares in the aggregate. Up to 1,000,000
of the founder shares may be surrendered by the Sponsor for no consideration depending on the extent to which the underwriters&#x2019;
over-allotment option is exercised. As a result of the underwriters&#x2019; election to fully exercise their over-allotment option on February
2, 2026, 1,000,000
founder shares are no longer subject to forfeiture by the Sponsor.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 26, 2026, the Sponsor granted membership interest equivalent to the aggregate of 175,000
founder shares to independent directors and an officer. All granted membership interests are in exchange for their services as directors
and officer through the Company&#x2019;s initial Business Combination. The transfer of founder shares to the independent directors and
officer is in the scope of FASB ASC Topic 718, &#x201c;Compensation-Stock Compensation&#x201d; (&#x201c;ASC 718&#x201d;). Under ASC 718, stock-based
compensation associated with equity classified awards is measured at fair value upon the assignment date. The total fair value of the
175,000
founder shares equivalents granted to the directors and officer was $459,550
or approximately $2.63
per share. The Company established the initial fair value founder shares on January 26, 2026, using a calculation prepared by a third
party valuation team which takes into consideration the implied share price of $9.88
and probability of de-SPAC and instrument-specific market adjustment of 26.6%.
Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business
Combination) in an amount equal to the number of founder shares that ultimately vest times the assignment date fair value per share (unless
subsequently modified) less the amount initially received for the transfer of founder shares. As of December 31, 2025, the Company determined
that the initial Business Combination is not considered probable and therefore no compensation expense has been recognized.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s initial shareholders have agreed not to transfer, assign or sell any of their founder shares and any Class&#160;A ordinary
shares issued upon conversion thereof until the earlier to occur of (i)&#160;six months after the completion of the initial Business Combination
or (ii)&#160;the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial
Business Combination that results in all of the Company&#x2019;s shareholders having the right to exchange their Class&#160;A ordinary
shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements
of the Company&#x2019;s initial shareholders with respect to any founder shares (the &#x201c;Lock-up&#x201d;). Notwithstanding the foregoing,
if (1)&#160;the closing price of the Class&#160;A ordinary shares equals or exceeds $12.00
per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20&#160;trading
days within any 30-trading&#160;day
period commencing at least 30&#160;days after the initial Business Combination or (2)&#160;if the Company consummates a transaction after
the initial Business Combination which results in the Company&#x2019;s shareholders having the right to exchange their shares for cash,
securities or other property, the founder shares will be released from the Lock-up.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Promissory
Note&#160;&#x2014;&#160;Related Party&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor has agreed to loan the Company an aggregate of up to $400,000
to be used for a portion of the expenses of the Initial Public Offering (the &#x201c;Promissory Note&#x201d;). The Promissory Note is non-interest
bearing, unsecured and due at the earlier of (i)&#160;October&#160;31, 2026 or (ii)&#160;the closing of the Initial Public Offering. As
of December 31, 2025, there was $124,790
outstanding under the Promissory Note. As of February 20, 2026, there was $302,954
outstanding under the Promissory Note, which was fully settled simultaneously with the closing of the Initial Public Offering. Borrowing
under the Promissory Note is no longer available.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Reimbursements
to Officers&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, the Company has incurred $48,395
for the services of the Chief Financial Officer and Chief Executive Officer, reimbursable office expenses, and for office space and administrative
support. These expenses are included in the general and administrative costs on the statement of operations.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Administrative
Services Agreement&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commencing
on the effective date of the securities of the Company are first listed, February 18, 2026, the Company entered into an agreement with
an affiliate of the Sponsor to pay an aggregate of $25,000
per month for the services of the Chief Financial Officer and Chief Operating Officer, and for office space and administrative support.
Upon completion of the initial Business Combination or the liquidation, the Company will cease paying the $25,000
per month fee. For the period from November 13, 2025 (inception) through December 31, 2025, the Company did not incur any fees of administrative
services.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Related
Party Loans&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor
or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required on a
non-interest basis (the &#x201c;Working Capital Loans&#x201d;). If the Company completes an initial Business Combination, the Company would
repay such loaned amounts. In the event that the initial Business Combination does not close, the Company may use amounts held outside
the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for such repayment. Up to $1,500,000
of such loans may be convertible into units of the post-Business Combination entity at a price of $10.00
per unit at the option of the lender. Such units would be identical to the Private Placement Units. Except as set forth above, the terms
of such loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2025, &lt;span style="-sec-ix-hidden:fc_1964203158"&gt;no&lt;/span&gt;
such Working Capital Loans were outstanding.&lt;/span&gt; &lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="cref_1729854016"
      decimals="0"
      id="ixv-10274"
      unitRef="uref_145379145">25000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1077444195"
      decimals="3"
      id="ixv-10275"
      unitRef="uref_138542282">0.003</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_360245387"
      decimals="0"
      id="ixv-10276"
      unitRef="uref_908877115">5750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_95296787"
      decimals="0"
      id="ixv-10277"
      unitRef="uref_908877115">1916667</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_734645114"
      decimals="0"
      id="ixv-10278"
      unitRef="uref_908877115">7666667</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_2134472946"
      decimals="0"
      id="ixv-10279"
      unitRef="uref_908877115">1000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="cref_1206883864"
      decimals="0"
      id="ixv-10280"
      unitRef="uref_908877115">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_931987691"
      decimals="0"
      id="ixv-10281"
      unitRef="uref_908877115">175000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="cref_130466136"
      decimals="0"
      id="ixv-10282"
      unitRef="uref_908877115">175000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross
      contextRef="cref_130466136"
      decimals="0"
      id="ixv-10283"
      unitRef="uref_145379145">459550</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_801357899"
      decimals="2"
      id="ixv-10284"
      unitRef="uref_138542282">2.63</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_2095354973"
      decimals="2"
      id="ixv-10285"
      unitRef="uref_138542282">9.88</us-gaap:SharesIssuedPricePerShare>
    <aacou:PercentageOfMarketAdjustment
      contextRef="cref_931987691"
      decimals="3"
      id="ixv-10286"
      unitRef="uref_414420850">0.266</aacou:PercentageOfMarketAdjustment>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_120717459"
      decimals="2"
      id="ixv-10287"
      unitRef="uref_138542282">12</us-gaap:SharesIssuedPricePerShare>
    <aacou:NumberOfTradingDaysOfBusinessCombination contextRef="cref_324529400" id="ixv-10288">P20D</aacou:NumberOfTradingDaysOfBusinessCombination>
    <aacou:NumberOfTradingDaysOfBusinessCombination contextRef="cref_2004087683" id="ixv-10289">P30D</aacou:NumberOfTradingDaysOfBusinessCombination>
    <us-gaap:OtherExpenses
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10290"
      unitRef="uref_145379145">400000</us-gaap:OtherExpenses>
    <us-gaap:NotesPayableCurrent
      contextRef="cref_143874339"
      decimals="0"
      id="ixv-10291"
      unitRef="uref_145379145">124790</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="cref_1845149687"
      decimals="0"
      id="ixv-10292"
      unitRef="uref_145379145">302954</us-gaap:NotesPayableCurrent>
    <aacou:ReimbursableOfficeExpenses
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10293"
      unitRef="uref_145379145">48395</aacou:ReimbursableOfficeExpenses>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_145379145"
      decimals="0"
      id="ixv-10294"
      unitRef="uref_145379145">25000</us-gaap:AdministrativeFeesExpense>
    <aacou:AggregateSponsorAmount
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10295"
      unitRef="uref_145379145">25000</aacou:AggregateSponsorAmount>
    <aacou:WorkingCapitalLoans
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10296"
      unitRef="uref_145379145">1500000</aacou:WorkingCapitalLoans>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="cref_2079974558"
      decimals="2"
      id="fc_2079974558"
      unitRef="uref_138542282">10</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="cref_32634712" id="ixv-9118">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;6
&#x2014;&#160;Commitments and Contingencies&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Risks
and Uncertainties&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The United States and global markets are experiencing
volatility and disruption following the geopolitical instability resulting from the military escalations between the United States and
Iran, the ongoing Russia-Ukraine conflict and other similar geopolitical conflicts. Ongoing military escalation between the United States
and Iran has heightened risks to critical infrastructure, shipping routes, and energy supplies. Any further deterioration could drive
sustained increases in oil prices, disrupt global trade, contribute to macroeconomic instability, and materially height the risk of a
global recession. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (&#x201c;NATO&#x201d;) deployed
additional military forces to eastern Europe, and the United&#160;States, the United Kingdom, the European Union and other countries have
announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal
of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication payment system. Certain countries,
including the United&#160;States, have also provided and may continue to provide military aid or other assistance to Ukraine and to Israel,
increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the Israel-Hamas conflict and the resulting
measures that have been taken, and could be taken in the future, by NATO, the United&#160;States, the United Kingdom, the European Union,
Israel and its neighboring states and other countries have created global security concerns that could have a lasting impact on regional
and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions,
including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions and increased
cyberattacks against U.S.&#160;companies. Additionally, any resulting sanctions could adversely affect the global economy and financial
markets and lead to instability and lack of liquidity in capital markets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July&#160;4, 2025, President Trump signed into law the One Big Beautiful Bill Act. FASB ASC&#160;740, &#x201c;Income Taxes&#x201d;, requires
the effects of changes in tax laws to be recognized in the period in which the legislation is enacted. The Company is currently evaluating
the impact of the new law. However, none of the tax provisions are expected to have a significant impact on the Company&#x2019;s financial
statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
of the above mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting
from these geopolitical conditions could reduce the pool of viable attractive target candidates for our initial business combination,
the Russian invasion of Ukraine, the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect the Company&#x2019;s
search for an initial Business Combination and any target business with which the Company may ultimately consummate an initial Business
Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Registration
Rights&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
holders of the (i)&#160;founder shares, which were issued in a private placement prior to the closing of the Initial Public Offering,
(ii)&#160;Private Placement Units&#160;(and the securities comprising such units and the Class&#160;A ordinary shares issuable upon exercise
of the Private Placement Warrants) which will be issued in a private placement simultaneously with the closing of the Initial Public Offering
and (iii)&#160;Private Placement Units&#160;(and the securities comprising such units and the Class&#160;A ordinary shares issuable upon
exercise of the Private Placement Warrants) that may be issued upon conversion of Working Capital Loans will have registration rights
to require the Company to register a sale of any of the Company&#x2019;s securities held by them and any other securities of the Company
acquired by them prior to the consummation of an initial Business Combination pursuant to a registration rights agreement to be signed
prior to or on the effective date of the Initial Public Offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such
securities. In addition, the holders have certain &#x201c;piggy-back&#x201d; registration rights with respect to registration statements
filed subsequent to the completion of an initial Business Combination. Notwithstanding anything to the contrary, BTIG, LLC may only make
a demand on one occasion and only during the five-year period beginning on the effective date of the registration statement relating to
our initial public offering. In addition, BTIG, LLC may participate in a &#x201c;piggy back&#x201d; registration only during the seven-year
period beginning on the effective date of the registration statement relating to our initial public offering. The Company will bear the
expenses incurred in connection with the filing of any such registration statements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Underwriting
Agreement&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company granted the underwriters a 45-day
option from the date of the Initial Public Offering to purchase up to an additional 3,000,000&#160;units
to cover over-allotments, if any. On February 20, 2026, the underwriters exercised their over-allotment option, closing on the 3,000,000
additional Units simultaneously with the Initial Public Offering.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
underwriters were paid a cash underwriting discount of 2.00%
of the gross proceeds of the units offered in the Initial Public Offering, or $4,600,000
upon the closing of the Initial Public Offering.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additionally,
the underwriters are entitled to a deferred underwriting discount of 3.50%
of the gross proceeds of the Initial Public Offering held in the Trust Account, $8,050,000,
payable to BTIG, LLC to be deposited in the Trust Account and released to BTIG, LLC only upon the completion of an initial Business Combination.
The deferred underwriting commissions are payable as follows: (i)&#160;$0.20
per Unit sold in the Initial Public Offering is paid to BTIG, LLC in cash upon the closing of the initial Business Combination and (ii)&#160;$0.15
per Unit sold in the Initial Public Offering is payable to BTIG, LLC in cash, based on the funds remaining in the Trust Account after
giving effect to public shares that are redeemed in connection with an initial Business Combination.&lt;/span&gt; &lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <aacou:UnderwritersOptionPeriodFromDateOfProposedPublicOffering contextRef="cref_507305422" id="ixv-10298">P45D</aacou:UnderwritersOptionPeriodFromDateOfProposedPublicOffering>
    <aacou:UnitsIssuedDuringPeriodSharesNewISsues
      contextRef="cref_215408277"
      decimals="0"
      id="ixv-10299"
      unitRef="uref_908877115">3000000</aacou:UnitsIssuedDuringPeriodSharesNewISsues>
    <aacou:UnderwritersPartiallyExercisedOverAllotmentOption
      contextRef="cref_445481486"
      decimals="0"
      id="ixv-10300"
      unitRef="uref_908877115">3000000</aacou:UnderwritersPartiallyExercisedOverAllotmentOption>
    <aacou:UnderwritingDiscountPercentage
      contextRef="cref_2007673822"
      decimals="4"
      id="ixv-10301"
      unitRef="uref_414420850">0.02</aacou:UnderwritingDiscountPercentage>
    <aacou:UnitsIssuedDuringPeriodSharesNewISsues
      contextRef="cref_414420850"
      decimals="0"
      id="ixv-10302"
      unitRef="uref_908877115">4600000</aacou:UnitsIssuedDuringPeriodSharesNewISsues>
    <aacou:DeferredUnderwritingDiscountRate
      contextRef="cref_2007673822"
      decimals="4"
      id="ixv-10303"
      unitRef="uref_414420850">0.035</aacou:DeferredUnderwritingDiscountRate>
    <aacou:TrustAccountPayable
      contextRef="cref_138542282"
      decimals="0"
      id="ixv-10304"
      unitRef="uref_145379145">8050000</aacou:TrustAccountPayable>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_823725382"
      decimals="2"
      id="ixv-10305"
      unitRef="uref_138542282">0.2</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1712126357"
      decimals="2"
      id="ixv-10306"
      unitRef="uref_138542282">0.15</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="cref_32634712" id="ixv-9192">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;7
&#x2014;&#160;Shareholder&#x2019;s Deficit&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Preference
Shares&lt;/i&gt;&lt;/span&gt;&#160;&#x2014;&#160;The Company is authorized to issue a total of 5,000,000
preference shares at par value of $0.0001
each. At December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_649126349"&gt;&lt;span style="-sec-ix-hidden:fc_1499412547"&gt;no&lt;/span&gt;&lt;/span&gt;
preference shares issued or outstanding.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Class&#160;A
Ordinary Shares&lt;/i&gt;&lt;/span&gt;&#160;&#x2014;&#160;The Company is authorized to issue a total of 500,000,000
Class&#160;A ordinary shares at par value of $0.0001
each. At December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_1306898314"&gt;&lt;span style="-sec-ix-hidden:fc_1983493946"&gt;no&lt;/span&gt;&lt;/span&gt;
Class&#160;A ordinary shares issued or outstanding.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Class&#160;B
Ordinary Shares&lt;/i&gt;&lt;/span&gt;&#160;&#x2014;&#160;The Company is authorized to issue a total of 50,000,000
Class&#160;B ordinary shares at par value of $0.0001
each. At December 31, 2025, there were 7,666,667
Class&#160;B ordinary shares issued and outstanding, of which an aggregate of up to 1,000,000
Class&#160;B ordinary shares are subject to forfeiture if the over-allotment option is not exercised by the underwriters in full. As a
result of the underwriters&#x2019; election to fully exercise their over-allotment option on February 20, 2026, 1,000,000
founder shares are no longer subject to forfeiture by the Sponsor.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
founder shares will automatically convert into Class&#160;A ordinary shares (which such Class&#160;A ordinary shares delivered upon conversion
will not have any redemption rights or be entitled to liquidating distributions from the Trust Account if the Company fails to consummate
an initial Business Combination) concurrently with or immediately following the consummation of an initial Business Combination or earlier
at the option of the holder on a one-for-one basis, subject to adjustment for share subdivisions, share capitalizations, reorganizations,
recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class&#160;A ordinary
shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering
and related to or in connection with the closing of the initial Business Combination, the ratio at which Class&#160;B ordinary shares
convert into Class&#160;A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class&#160;B ordinary
shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class&#160;A ordinary
shares issuable upon conversion of all Class&#160;B ordinary shares will equal, in the aggregate, 25%
of the sum of (i)&#160;the total number of all Class&#160;A ordinary shares outstanding upon the completion of the Initial Public Offering
(including any Class&#160;A ordinary shares issued pursuant to the underwriters&#x2019; over-allotment option and excluding the Class&#160;A
ordinary shares comprising part of the Private Placement Units&#160;and the Class&#160;A ordinary shares underlying the Private Placement
Warrants), plus (ii)&#160;all Class&#160;A ordinary shares and equity-linked securities issued or deemed issued, in connection with the
closing of the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in
the initial Business Combination and any private placement-equivalent units issued to the Sponsor or any of its affiliates or to the Company&#x2019;s
officers or directors upon conversion of Working Capital Loans) minus (iii)&#160;any redemptions of Class&#160;A ordinary shares by public
shareholders in connection with an initial Business Combination and any Class&#160;A ordinary shares redeemed by public shareholders in
connection with any amendment to the amended and restated memorandum and articles of association made prior to the consummation of the
initial Business Combination (A)&#160;to modify the substance or timing of the Company&#x2019;s obligation to allow redemption in connection
with the initial Business Combination or to redeem 100%
of our public shares if the Company does not complete the initial Business Combination within the completion window or (B)&#160;with respect
to any other material provisions relating to the rights of holders of Class&#160;A ordinary shares or pre-business combination activity;
provided that such conversion of founder shares will never occur on a less than one-for-one basis.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Holders
of record of the Company&#x2019;s Class&#160;A ordinary shares and Class&#160;B ordinary shares are entitled to one vote for each share
held on all matters to be voted on by shareholders. Unless specified in the Company&#x2019;s amended and restated memorandum and articles
of association or as required by the Companies Act or stock exchange rules, an ordinary resolution under Cayman Islands law and the Company&#x2019;s
amended and restated memorandum and articles of association, which requires the affirmative vote of at least a majority of the votes cast
by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting
of the Company is generally required to approve any matter voted on by the Company&#x2019;s shareholders. Approval of certain actions requires
a special resolution under Cayman Islands law, which (except as specified below) requires the affirmative vote of at least two-thirds
of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable
general meeting, and pursuant to the Company&#x2019;s amended and restated memorandum and articles of association, such actions include
amending the Company&#x2019;s amended and restated memorandum and articles of association and approving a statutory merger or consolidation
with another company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
is no cumulative voting with respect to the appointment of directors, meaning, following the Company&#x2019;s initial Business Combination,
the holders of more than 50%
of the Company&#x2019;s ordinary shares voted for the appointment of directors can elect all of the directors. Prior to the consummation
of an initial Business Combination, only holders of the Company&#x2019;s Class&#160;B ordinary shares will (i)&#160;have the right to vote
on the appointment and removal of directors and (ii)&#160;be entitled to vote on continuing the Company in a jurisdiction outside the
Cayman Islands (including any special resolution required to amend our constitutional documents or to adopt new constitutional documents,
in each case, as a result of approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). Holders of the
Company&#x2019;s Class&#160;A ordinary shares will not be entitled to vote on these matters during such time. These provisions of the Company&#x2019;s
amended and restated memorandum and articles of association may only be amended if approved by a special resolution passed by the affirmative
vote of at least 90%
(or, where such amendment is proposed in respect of the consummation of an initial Business Combination, two-thirds) of the votes cast
by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting
of the Company.&lt;/span&gt; &lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_1219919515"
      decimals="0"
      id="ixv-10307"
      unitRef="uref_908877115">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_1219919515"
      decimals="4"
      id="ixv-10308"
      unitRef="uref_138542282">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_1701158294"
      decimals="0"
      id="ixv-10309"
      unitRef="uref_908877115">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1701158294"
      decimals="4"
      id="ixv-10310"
      unitRef="uref_138542282">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_998287359"
      decimals="0"
      id="ixv-10311"
      unitRef="uref_908877115">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_998287359"
      decimals="4"
      id="ixv-10312"
      unitRef="uref_138542282">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_998287359"
      decimals="0"
      id="ixv-10313"
      unitRef="uref_908877115">7666667</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_998287359"
      decimals="0"
      id="ixv-10314"
      unitRef="uref_908877115">7666667</us-gaap:CommonStockSharesOutstanding>
    <aacou:NumberOfOrdinarySharesSubjectToForfeitureIfTheOverallotmentOptionIsNotExercised
      contextRef="cref_998287359"
      decimals="0"
      id="ixv-10315"
      unitRef="uref_908877115">1000000</aacou:NumberOfOrdinarySharesSubjectToForfeitureIfTheOverallotmentOptionIsNotExercised>
    <aacou:NumberOfSharesAreNoLongerSubjectToForfeiture
      contextRef="cref_1198982694"
      decimals="0"
      id="ixv-10316"
      unitRef="uref_908877115">1000000</aacou:NumberOfSharesAreNoLongerSubjectToForfeiture>
    <aacou:PercentageOfSharesUponConversion
      contextRef="cref_1021116441"
      decimals="2"
      id="ixv-10317"
      unitRef="uref_414420850">0.25</aacou:PercentageOfSharesUponConversion>
    <aacou:PercentageOfPublicShares
      contextRef="cref_1021116441"
      decimals="2"
      id="ixv-10318"
      unitRef="uref_414420850">1</aacou:PercentageOfPublicShares>
    <aacou:PercentageOfInitialBusinessCombinationHolders
      contextRef="cref_1021116441"
      decimals="2"
      id="ixv-10319"
      unitRef="uref_414420850">0.50</aacou:PercentageOfInitialBusinessCombinationHolders>
    <aacou:MinimumPercentageOfVotingInterestsToBeAcquiredInBusinessCombination
      contextRef="cref_1021116441"
      decimals="2"
      id="ixv-10320"
      unitRef="uref_414420850">0.90</aacou:MinimumPercentageOfVotingInterestsToBeAcquiredInBusinessCombination>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="cref_32634712" id="ixv-9259">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;8
&#x2014;&#160;Segment Information&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FASB
ASC Topic&#160;280, &#x201c;Segment Reporting&#x201d;, establishes standards for companies to report, in their financial statements, information
about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an
enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial
information is available that is regularly evaluated by the Company&#x2019;s CODM, or group, in deciding how to allocate resources and
assess performance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s CODM has been identified as the &lt;span style="-sec-ix-hidden:fc_419880054"&gt;Chief Executive Officer&lt;/span&gt;, who reviews
the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly,
management has determined that the Company only has one
reportable segment.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported
on the statement of operations as net income or loss. The measure of segment assets is reported on the balance sheet as
total assets.
When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics
included in net income or loss and total assets, which include the following:&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred offering costs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;351,275&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
        &lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;For
        the&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Period
        from&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;November
        13,&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;(Inception)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;through&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;December
        31,&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;General and administrative
        costs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;99,715&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
        &lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
CODM reviews general and administrative costs to manage and forecast cash to ensure enough capital is available to complete a Business
Combination or similar transaction within the Business Combination period. The CODM also reviews general and administrative costs to manage,
maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. General and administrative
costs, as reported on the statement of operations, are the significant segment expenses provided to the CODM on a regular basis. All other
segment items included in net income or loss are reported on the statement of operations and described within their respective disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
CODM reviews the position of total assets available with the Company to assess if the Company has sufficient resources available to discharge
its liabilities. The CODM is provided with details of cash and liquid resources available with the Company. Additionally, the CODM regularly
reviews the status of deferred costs incurred to assess if these are in line with the planned use of proceeds to be raised from the public
offering.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10321"
      unitRef="uref_1967954440">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription contextRef="cref_1021116441" id="ixv-10322">The
CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported
on the statement of operations as net income or loss.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="cref_32634712" id="ixv-10323">
When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics
included in net income or loss and total assets, which include the following:

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred offering costs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;351,275&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
        &lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;For
        the&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Period
        from&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;November
        13,&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;(Inception)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;through&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;December
        31,&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;General and administrative
        costs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;99,715&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
        &lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:DeferredOfferingCosts
      contextRef="cref_129871934"
      decimals="0"
      id="ixv-10324"
      unitRef="uref_145379145">351275</us-gaap:DeferredOfferingCosts>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_1021116441"
      decimals="0"
      id="ixv-10325"
      unitRef="uref_145379145">99715</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:SubsequentEventsTextBlock contextRef="cref_32634712" id="ixv-9389">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;9
&#x2014;&#160;Subsequent Events&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the financial statements
were issued. Based upon this review, other than noted below, the Company did not identify any subsequent events that would have required
adjustment or disclosure in the financial statement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 26, 2026, the Sponsor granted membership interest equivalent to the aggregate of 175,000
founder shares to independent directors and an officer.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
registration statement for the Company&#x2019;s Initial Public Offering was declared effective on January 30, 2026. On February 20, 2026,
the Company consummated its Initial Public Offering, which consisted of 23,000,000
Units, generating gross proceeds to the Company of $230,000,000.&lt;/span&gt;
&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of 695,000
Private Placement Units to the Sponsor and BTIG, LLC, generating gross proceeds of $6,950,000.
Of those 695,000
Private Placement Units, the Sponsor purchased 465,000
Private Placement Units and BTIG, LLC purchased 230,000
Private Placement Units.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the closing of the Initial Public Offering on February 20, 2026, an amount of $230,000,000
($10.00
per Unit) from the net proceeds of the sale of the Units, and a portion of the net proceeds from the sale of the Private Placement Units,
was held in the Trust Account.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
underwriters were paid a cash underwriting discount of 2.00%
of the gross proceeds of the units offered in the Initial Public Offering, or $4,600,000
upon the closing of the Initial Public Offering. Additionally, the underwriters are entitled to a deferred underwriting discount of 3.50%
of the gross proceeds of the Initial Public Offering held in the Trust Account, $8,050,000,
payable to BTIG, LLC to be deposited in the Trust Account and released to BTIG, LLC only upon the completion of an initial Business Combination.&lt;/span&gt;
&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
the closing of the Initial Public Offering, the $302,954
outstanding under the Promissory Note was fully settled. Borrowings under the note are no longer available.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commencing
on the effective date of the securities of the Company are first listed, February 18, 2026, the Company entered into an agreement with
an affiliate of the Sponsor to pay an aggregate of $25,000
per month for the services of the Chief Financial Officer and Chief Operating Officer and for office space and administrative support.&lt;/span&gt;
&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_587895388"
      decimals="0"
      id="ixv-10326"
      unitRef="uref_908877115">175000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_138542282"
      decimals="0"
      id="ixv-10327"
      unitRef="uref_908877115">23000000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_1262656910"
      decimals="0"
      id="ixv-10328"
      unitRef="uref_145379145">230000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_639467079"
      decimals="0"
      id="ixv-10329"
      unitRef="uref_908877115">695000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_1295773837"
      decimals="0"
      id="ixv-10330"
      unitRef="uref_145379145">6950000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_639467079"
      decimals="0"
      id="ixv-10331"
      unitRef="uref_908877115">695000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_873881575"
      decimals="0"
      id="ixv-10332"
      unitRef="uref_908877115">465000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_533141458"
      decimals="0"
      id="ixv-10333"
      unitRef="uref_908877115">230000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_414420850"
      decimals="0"
      id="ixv-10334"
      unitRef="uref_145379145">230000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <aacou:NumberOfUnitsSoldPricePerUnit
      contextRef="cref_138542282"
      decimals="2"
      id="ixv-10335"
      unitRef="uref_138542282">10</aacou:NumberOfUnitsSoldPricePerUnit>
    <aacou:PercentageOfCashUnderwritingDiscount
      contextRef="cref_2007673822"
      decimals="4"
      id="ixv-10336"
      unitRef="uref_414420850">0.02</aacou:PercentageOfCashUnderwritingDiscount>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_908877115"
      decimals="0"
      id="ixv-10337"
      unitRef="uref_908877115">4600000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <aacou:PercentageOfDeferredUnderwritingDiscount
      contextRef="cref_414420850"
      decimals="4"
      id="ixv-10338"
      unitRef="uref_414420850">0.035</aacou:PercentageOfDeferredUnderwritingDiscount>
    <aacou:TrustAccountPayable
      contextRef="cref_1037697349"
      decimals="0"
      id="ixv-10339"
      unitRef="uref_145379145">8050000</aacou:TrustAccountPayable>
    <us-gaap:NotesPayableCurrent
      contextRef="cref_256662356"
      decimals="0"
      id="ixv-10340"
      unitRef="uref_145379145">302954</us-gaap:NotesPayableCurrent>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_145379145"
      decimals="0"
      id="ixv-10341"
      unitRef="uref_145379145">25000</us-gaap:AdministrativeFeesExpense>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#fc_707120496"
          xlink:label="fc_707120496"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_333249326"
          xlink:label="fc_333249326"
          xlink:type="locator"/>
        <link:footnote id="fref_412258990" xlink:label="fref_412258990" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Excludes up to 1,000,000
                    Class&#160;B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters
                    On February 20, 2026, the underwriters exercised their over-allotment option in full to be settled as part of the closing of the Initial
                    Public Offering. As a result of the underwriters&#x2019; election to fully exercise their over-allotment option, 1,000,000
                    founder shares are no longer subject to forfeiture by the Sponsor (Note 7).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_707120496"
          xlink:to="fref_412258990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_333249326"
          xlink:to="fref_412258990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_1278202245"
          xlink:label="fc_1278202245"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1203351570"
          xlink:label="fc_1203351570"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1284822420"
          xlink:label="fc_1284822420"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1130686897"
          xlink:label="fc_1130686897"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1601694498"
          xlink:label="fc_1601694498"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_536763980"
          xlink:label="fc_536763980"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_578705586"
          xlink:label="fc_578705586"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1927365081"
          xlink:label="fc_1927365081"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_865496791"
          xlink:label="fc_865496791"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_381857652"
          xlink:label="fc_381857652"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1884791732"
          xlink:label="fc_1884791732"
          xlink:type="locator"/>
        <link:footnote id="fref_1901319485" xlink:label="fref_1901319485" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes up to 1,000,000
                    Class&#160;B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.
                    On February 20, 2026, the underwriters exercised their over-allotment option in full to be settled as part of the closing of the Initial
                    Public Offering. As a result of the underwriters&#x2019; election to fully exercise their over-allotment option, 1,000,000
                    founder shares are no longer subject to forfeiture by the Sponsor (Note 7).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1278202245"
          xlink:to="fref_1901319485"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1203351570"
          xlink:to="fref_1901319485"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1284822420"
          xlink:to="fref_1901319485"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1130686897"
          xlink:to="fref_1901319485"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1601694498"
          xlink:to="fref_1901319485"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_536763980"
          xlink:to="fref_1901319485"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_578705586"
          xlink:to="fref_1901319485"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1927365081"
          xlink:to="fref_1901319485"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_865496791"
          xlink:to="fref_1901319485"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_381857652"
          xlink:to="fref_1901319485"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1884791732"
          xlink:to="fref_1901319485"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
